about
An introduction to molecular imaging in radiation oncology: a report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR)MR spectroscopic imaging: principles and recent advances.Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.(1)H MR spectroscopic imaging of the prostate at 7T using spectral-spatial pulses.Hierarchical non-negative matrix factorization applied to three-dimensional 3 T MRSI data for automatic tissue characterization of the prostate.Simple baseline correction for 1H MRSI data of the prostate.Quality control of prostate 1 H MRSI data.In vivo (1) H MR spectroscopic imaging of aggressive prostate cancer: can we detect lactate?Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.ProstateAnalyzer: Web-based medical application for the management of prostate cancer using multiparametric MR imaging.Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerProton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach.Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancerMagnetic resonance imaging for prostate cancer clinical applicationThe role of metabolic imaging in radiation therapy of prostate cancer.Integrating multiparametric prostate MRI into clinical practice.Role of high-field MR in studies of localized prostate cancer.Mapping of prostate cancer by 1H MRSI.Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.Metabolite ratios in 1H MR spectroscopic imaging of the prostate.Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.Multiparametric MRI for localized prostate cancer: lesion detection and staging.Multiparametric MRI of the prostate gland: technical aspects.Investigation of the PSF-choice method for reduced lipid contamination in prostate MR spectroscopic imaging.The value of prostate MRI with endorectal coil in detecting seminal vesicle involvement in patients with prostate cancer.Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values.Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.Stellenwert der multiparametrischen Magnetresonanztomographie beim Prostatakarzinom
P2860
Q27002845-34AD6AA3-18EC-4F65-9FFC-5B7DC86EFC89Q30578725-22C59534-46B3-4B2D-803D-209F44E4EF50Q30755589-FCE03C55-7098-4579-BBBB-939C0C8CE463Q30944933-85E967B5-31C0-4D34-9889-6C1BBB329D90Q31072477-31560647-1264-4D31-8809-15FC1131DFCBQ34147349-94A9AD8D-B55F-489C-9A72-58C727C807E1Q34341015-3ECBC14F-90EC-492E-8ED0-8AA8167942CFQ34615828-5CEC967E-9A33-43AC-8EDF-D83964FAC07EQ34693066-36F39516-C2CD-4FF2-90E5-AA80D5BC5488Q35566952-B7CB34E8-EB44-4C58-9D63-B0DA76D86EECQ35722781-CD733810-9449-4D68-B67D-AFBF4F80616BQ36462756-9FE15E10-0C50-4F1A-B0FF-F66A2D55DDC3Q36609888-9DE4251E-94FB-4236-A65A-4345A37B0188Q36738856-8CB2F250-D024-4291-8C3F-3A19D03DEC4CQ36767668-5E4FD77D-181A-4D0E-96CE-55638FD651AEQ37395733-2CE62BDC-455D-4C9D-A8A2-3F742F04EA4FQ37970305-542C52B5-7AF1-4C0C-A077-FC543554C364Q38109111-A11BA2C5-FC8F-4392-9D9E-414225AA1828Q38114017-A99C691A-D077-4299-82B1-9A81F3794161Q38163488-3167111E-D9E7-4C21-B868-5D3FF1ED5D78Q38184479-809005B0-9818-4F37-B82A-AE574EDD51F6Q38190885-B74A8690-A607-42EC-99B1-AB02547675C7Q38294503-99ADFA96-8E60-4095-B1D3-6F4D967FE726Q38830576-33CEAD9C-E6E3-4408-9A8E-5BFA881B832AQ42323452-AB45CC18-9C19-4152-B60A-70FB53CFA877Q43174856-7B3FC973-B88A-4610-9F9F-51725BF3EFF1Q46051598-BDA94F4D-6427-4636-9309-C52FFECF2DE6Q46567823-23414417-3900-4104-A5D2-9D10937B9904Q48098858-05A536A6-F917-403E-9965-EA60AE8DD516Q51074429-C895E448-81D9-48B6-BC59-1E330EB34ADEQ53098704-D26627CF-8B56-4609-AF07-E42A587D908EQ53135999-CBDDF8F5-1C94-4E4B-B7DE-09ABAEC63051Q57712636-48914D76-5B28-4610-B3FC-4603C64E963F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prostate MRI and 3D MR spectroscopy: how we do it
@ast
Prostate MRI and 3D MR spectroscopy: how we do it
@en
type
label
Prostate MRI and 3D MR spectroscopy: how we do it
@ast
Prostate MRI and 3D MR spectroscopy: how we do it
@en
prefLabel
Prostate MRI and 3D MR spectroscopy: how we do it
@ast
Prostate MRI and 3D MR spectroscopy: how we do it
@en
P2093
P2860
P356
P1476
Prostate MRI and 3D MR spectroscopy: how we do it
@en
P2093
Arumugam Rajesh
Baris Turkbey
John Kurhanewicz
Jurgen J Fütterer
Peter L Choyke
Sadhna Verma
Tom W J Scheenen
P2860
P304
P356
10.2214/AJR.10.4312
P407
P577
2010-06-01T00:00:00Z